Department of Medicine, Division of Infectious Diseases and Immunology
Enterococcus faecalis; Vancomycin Resistance
Bacterial Infections and Mycoses | Epidemiology | Immunology and Infectious Disease | Microbiology
We read the article of Hayakawa et al with great interest. The report describes the growing prevalence of vancomycin-resistant Enterococcus faecalis in Michigan, a state that also has the most reports of vancomycin-resistant Staphylococcus aureus. Similar findings were reported in the tigecycline evaluation and surveillance trial (TEST). During the 2004–2009 period, 4.6% of 3,753 E. faecalis isolates were vancomycin resistant, with the highest rates of 7.6% in the East North Central region of United States. Here we report rates and trends of vancomycin-resistant E. faecalis in the East North Central region compared with national rates from 1999 to 2010.
Rights and Permissions
Citation: Gandra S, Braykov N, Laxminarayan R. East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States. Infect Control Hosp Epidemiol. 2013 Apr;34(4):443-5. doi: 10.1086/669872. Link to article on publisher's site
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America
Gandra, Sumanth; Braykov, Nikolay; and Laxminarayan, Ramanan, "East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States" (2013). University of Massachusetts Medical School Faculty Publications. 112.